HQ: Cambridge, United Kingdom • Rare Disease Therapeutics • Cardiometabolic Therapeutics • Oncology Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 1999 • Trust A • Hiring 727, 204 new
AstraZeneca is a British-Swedish pharmaceutical company formed in 1999 by the merger of Astra of Sweden and Zeneca of the United Kingdom, and now one of the largest drug makers in the world by revenue. Its portfolio is concentrated in oncology with Tagrisso, Imfinzi and Enhertu, alongside cardiovascular, renal and metabolic products including Farxiga, respiratory and immunology medicines, and a rare disease business built on the acquisition of Alexion. Headquartered in Cambridge in England and listed in London, Stockholm and New York, it reports in United States dollars.
Aradhana Sarin · Chief Financial Officer · decision-maker
Pascal Soriot · Chief Executive Officer · decision-maker
Careers mailbox is known
Head+ • 12+ years exp • In office (Cambridge, United States) • Master's Degree • Full-Time • Senior
$116k – $173k per year • Senior • 4+ years exp • In office (Cambridge, United States) • PhD • Full-Time • Senior
Python
R
R
ggplot2
Bioconductor
AI/ML
Scikit-learn
Agentic Workflows
LLM
Machine Learning
AI Agents
Structured Outputs
Multi-Agent Systems
TensorFlow
Prompt Engineering
Claude Code
PyTorch
Copilot
RAG
DevOps
SLURM
HPC
Unix
GitHub
Git
Linux
GCP
AWS
Life Sciences
Next-Generation Sequencing
Single-Cell Sequencing
+19
$244k – $336k per year • Lead • 5+ years exp • Hybrid (Cambridge, United States) • PhD • Full-Time • Staff
HQ: North Chicago, United States • Neurology & CNS Therapeutics • Oncology Therapeutics • Immunology & Inflammation Therapeutics • Prescription Drugs • 5000+ employees • Est. 2013 • NYSE: ABBV • Trust B • Hiring 983, 210 new
AbbVie is an American biopharmaceutical company created in 2013 when Abbott Laboratories separated its research-based drug business into a standalone listed company. It was built around the immunology drug Humira, once the highest selling medicine in the world, and has since replaced that revenue with the successor immunology drugs Skyrizi and Rinvoq, an oncology portfolio led by Imbruvica and Venclexta, neuroscience products including Botox Therapeutic and Vraylar, and the aesthetics business acquired with Allergan. Headquartered in North Chicago and listed on the New York Stock Exchange, it is one of the largest pharmaceutical companies by revenue.
Richard Gonzalez · Founding Chief Executive Officer · decision-maker
Laura Schumacher · Executive Officer · decision-maker
Carlos Alban · Executive Officer · decision-maker
William Chase · Executive Officer · decision-maker
No careers mailbox known
$125k – $237k per year • Lead • 14+ years exp • In office (Cambridge, United States) • PhD • Full-Time • Senior • English
$182k – $346k per year • Head+ • 10+ years exp • Hybrid (Cambridge, United States) • Bachelor's Degree • Full-Time • Staff • English
$97k – $184k per year • Senior • In office (Cambridge, United States) • PhD • Full-Time • Middle • English
Python
Life Sciences
Flow Cytometry
ELISA
Cell Culture
Next-Generation Sequencing
Single-Cell Sequencing
GraphPad Prism
HQ: Paris, France • Vaccines • Rare Disease Therapeutics • Immunology & Inflammation Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 1973 • NASDAQ: SNY • Trust A • Hiring 740, 122 new
Sanofi is a French pharmaceutical company formed in 1973 and assembled over five decades through a long series of mergers including Synthelabo, Aventis and Genzyme. It is now built around immunology and rare disease, with Dupixent for atopic dermatitis and asthma as by far its largest product, alongside a substantial vaccines division covering influenza, meningitis and the respiratory syncytial virus antibody Beyfortus. Headquartered in Paris, the group has sharpened its focus in recent years by separating its consumer healthcare business into the standalone company Opella and directing research spending toward biologics and immune science.
Frederic Oudéa · Président du conseil d’administration · decision-maker
Belen Garijo Lopez · Directeur Général, Administrateur · decision-maker
Audrey Duval · Director · decision-maker
Frederic Oudea · Chairman of the Board · decision-maker
No careers mailbox known
$122k – $177k per year • Junior • 1+ year exp • In office (Cambridge, United States) • Bachelor's Degree • Full-Time • Junior
$146k – $211k per year • Junior • 2+ years exp • In office (Cambridge, United States) • Relocation • PhD • Full-Time • Junior
$114k per year • In office (Cambridge, United States) • Relocation • PhD • Full-Time
HQ: Cambridge, United States • Nonprofits & Foundations • Genomics & Genetic Testing • Bioinformatics • Research Institutes • 501-1000 employees • Est. 2004 • Hiring 25, 7 new
The Broad Institute is a biomedical and genomic research centre founded jointly by MIT and Harvard to tackle problems that need scale beyond a single university laboratory. Its data sciences platform develops machine learning methods for genomics, cancer biology and drug discovery, and maintains widely used open tools, datasets and cloud analysis platforms. The institute also runs one of the largest genome sequencing operations in the world; its researchers work jointly with the two universities and with hospitals across the Boston area.
No named decision-maker yet.
No careers mailbox known
In office (Cambridge, United States) • PhD
Python
AI/ML
PubMed
Life Sciences
CRISPR
Next-Generation Sequencing
Single-Cell Sequencing
In office (Cambridge, United States) • PhD
Python
Life Sciences
Cell Culture
≈ $68k – $141k per year (Estimated) • Junior • 2+ years exp • Cambridge • Remote (United States) • PhD • Junior
HQ: Tokyo, Japan • Neurology & CNS Therapeutics • Rare Disease Therapeutics • Oncology Therapeutics • Prescription Drugs • 5000+ employees • Est. 1781 • Trust A • Hiring 1055, 113 new
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise specializing in the research, development, and commercialization of targeted human therapeutics. The company focuses on core therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. Headquartered in Tokyo, Japan, it maintains extensive research, manufacturing, and commercial operations across more than 80 countries in Asia-Pacific, North America, Europe, and Latin America.
No named decision-maker yet.
Careers mailbox is known
$287k – $451k per year • Head+ • In office (Cambridge, United States) • PhD • Full-Time • Architect
$192k – $302k per year • Head+ • In office (Cambridge, United States) • PhD • Full-Time • Architect
$177k – $278k per year • Head+ • 10+ years exp • In office (Cambridge, United States) • Bachelor's Degree • Full-Time • Architect
GCP
Life Sciences
Good Clinical Practice
HQ: Rahway, United States • Biologics & Biosimilars • Veterinary Medicine • Vaccines • Oncology Therapeutics • Prescription Drugs • 5000+ employees • Est. 1891 • Trust A • Hiring 782, 190 new
Merck & Co. is an American pharmaceutical company founded in 1891 as the United States arm of the German firm Merck and made independent after the First World War, trading as MSD outside the United States and Canada. Its portfolio is dominated by the immuno-oncology drug Keytruda, alongside vaccines such as Gardasil and Vaxneuvance, hospital acute care products, and a large animal health business covering livestock and companion animals. The company is headquartered in Rahway, New Jersey, listed on the New York Stock Exchange, and spends a very large share of revenue on research into oncology, infectious disease and cardiometabolic therapies.
Dean Li · President, Merck Research Laboratories · decision-maker
Robert Davis · Chairman and Chief Executive Officer · decision-maker
George Merck · Founder · founder
Careers mailbox is known
$236k – $372k per year • Head+ • 13+ years exp • In office (Boston, Cambridge, United States) • Relocation • Bachelor's Degree • Full-Time • Architect
Knowledge Graph
Machine Learning
$119k – $188k per year • Senior • 5+ years exp • In office (Cambridge, United States) • Relocation • Bachelor's Degree • Full-Time • Senior
Microsoft Excel
Life Sciences
qPCR
PCR
Flow Cytometry
ELISA
GraphPad Prism
$194k – $306k per year • Senior • 7+ years exp • In office (Cambridge, United States) • Relocation • Bachelor's Degree • Full-Time • Senior
HQ: Bedford, United States • Oncology Therapeutics • Drug Discovery • 11-50 employees • Est. 2002 • Hiring 7, 4 new
Obsidian Therapeutics is using its proprietary cytoDRiVE® platform to harness the power of proteins to engineer precision medicines.
Peter Barrett · Executive Officer, Director · decision-maker
Michael Gilman · Executive Officer, Director · decision-maker
David Neafus · Executive Officer · decision-maker
Karen Hong · Director
Careers mailbox is known
$70k – $86k per year • Equity • Junior • 1+ year exp • In office (Cambridge, United States) • Relocation • Bachelor's Degree • Contractor • Junior
Obsidian
Life Sciences
Flow Cytometry
Cell Culture
$70k – $86k per year • Equity • Junior • 1+ year exp • In office (Cambridge, United States) • Relocation • Bachelor's Degree • Contractor • Junior
Obsidian
Life Sciences
Flow Cytometry
ELISA
Cell Culture
FlowJo
Benchling
GraphPad Prism
HQ: Cambridge, United States • Prescription Drugs • Neurology & CNS Therapeutics • 1001-5000 employees • Est. 1978 • NASDAQ: BIIB • Trust B • Hiring 177, 22 new
Headquartered in Cambridge, Massachusetts, Biogen is a global biotechnology enterprise specializing in the research, development, and delivery of therapies for complex neurological and neurodegenerative conditions. The company's portfolio features targeted treatments for diseases such as multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and rare neuromuscular disorders. Through scientific innovation and biopharmaceutical engineering, the organization advances specialized care to improve patient outcomes worldwide.
No named decision-maker yet.
No careers mailbox known
$122k – $163k per year • Equity • Middle • 4+ years exp • Hybrid (Cambridge, United States) • Bachelor's Degree • Full-Time • Middle
$122k – $163k per year • Equity • Senior • 4+ years exp • Hybrid (Cambridge, United States) • Relocation • PhD • Full-Time • Senior
$183k – $252k per year • Equity • Head+ • 3+ years exp • Hybrid (Cambridge, United States) • PhD • Full-Time • Architect
HQ: Basel, Switzerland • Oncology Therapeutics • Neurology & CNS Therapeutics • Immunology & Inflammation Therapeutics • Cardiometabolic Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 1996 • Trust B • Hiring 585, 109 new
Novartis is a Swiss pharmaceutical company created in 1996 by the merger of Ciba-Geigy and Sandoz, two Basel chemical and drug houses with roots in the nineteenth century. It has spent the past decade narrowing itself into a pure innovative medicines business, spinning off its generics arm as Sandoz in 2023 and its eye care business as Alcon in 2019, and now concentrates on cardiovascular, immunology, neuroscience and oncology, including radioligand therapies and gene therapy. Headquartered in Basel and listed in Zurich and New York, it is among the largest research spenders in the industry.
Harry Kirsch · Chief Financial Officer · decision-maker
Vas Narasimhan · Chief Executive Officer · decision-maker
Careers mailbox is known
$58k – $107k per year • Equity • Hybrid (Cambridge, United States) • Relocation • Bachelor's Degree • Full-Time
Machine Learning
Life Sciences
ELISA
Western Blot
Cell Culture
GraphPad Prism
Design of Experiments
$99k – $183k per year • Equity • Senior • In office (Cambridge, United States) • Relocation • Master's Degree • Full-Time • Senior
Machine Learning
Life Sciences
qPCR
Flow Cytometry
Antibody Engineering
Cell Culture
$94k – $174k per year • Equity • Senior • 4+ years exp • In office (Cambridge, United States) • Relocation • PhD • Full-Time • GMP / cleanroom • Senior
Machine Learning
Life Sciences
Cell Culture
Design of Experiments
HQ: Thousand Oaks, United States • Immunology & Inflammation Therapeutics • Cardiometabolic Therapeutics • Prescription Drugs • Biologics & Biosimilars • 5000+ employees • Est. 1980 • Trust A • Hiring 1011, 73 new
Amgen is an American biotechnology company founded in Thousand Oaks in 1980 that became one of the first firms to turn recombinant protein research into large commercial medicines. Its history rests on Epogen and Neupogen, and its current portfolio spans bone health with Prolia and Evenity, inflammation with Otezla and Tezspire, cardiovascular disease with Repatha, oncology including the bispecific antibody Blincyto, and a biosimilars business built on its own manufacturing capacity. The company is listed on Nasdaq, is a component of the Dow Jones Industrial Average, and expanded further into rare disease through its acquisition of Horizon Therapeutics.
Jay Bradner · Chief Scientific Officer · decision-maker
Robert Bradway · Chairman and Chief Executive Officer · decision-maker
George Rathmann · Founding Chief Executive Officer · founder
Careers mailbox is known
$142k – $192k per year • Lead • 4+ years exp • In office (Cambridge, Thousand Oaks, United States) • Bachelor's Degree • Full-Time • GMP / cleanroom • Principal
$90k – $122k per year • Junior • 3+ years exp • In office (Cambridge, United States) • Bachelor's Degree • Full-Time • Junior
Cell Culture
Chromatography
Bioreactors
Design of Experiments
$75k – $101k per year • Middle • 4+ years exp • In office (Cambridge, United States) • High School Diploma • Full-Time • GMP / cleanroom • Middle
Cell Culture
Chromatography
Bioreactors
Design of Experiments
HQ: Tarrytown, United States • Biotechnology • Health Care • Oncology Therapeutics • Immunology & Inflammation Therapeutics • Prescription Drugs • Biologics & Biosimilars • 201-500 employees • Trust B • Hiring 452, 63 new
Headquartered in Tarrytown, New York, United States, Regeneron Pharmaceuticals is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. The company accelerates traditional drug development using proprietary technologies, such as VelociSuite, alongside advanced genetic sequencing to uncover novel biological insights. Supported by a robust research and development pipeline, its innovative therapeutics provide proven treatments for patients suffering from cancer, eye diseases, inflammatory disorders, and rare conditions.
No named decision-maker yet.
No careers mailbox known
$205k – $342k per year • Equity • Head+ • 10+ years exp • Hybrid (Cambridge, New Brunswick, Tarrytown, United States) • PhD • Full-Time • Architect
Equity • Head+ • 12+ years exp • Hybrid (Cambridge, United States) • PhD • Full-Time • Senior
$176k – $287k per year • Equity • Head+ • 10+ years exp • Hybrid (Tarrytown, Cambridge, United States) • PhD • Full-Time • Architect
HQ: Princeton, United States • Cardiometabolic Therapeutics • Biologics & Biosimilars • Oncology Therapeutics • Prescription Drugs • 5000+ employees • Est. 1887 • Trust A • Hiring 390, 51 new
Bristol Myers Squibb is an American pharmaceutical company whose predecessors date to 1858 and 1887 and which took its present form in a 1989 merger. Its portfolio is concentrated in oncology, haematology, immunology and cardiovascular disease, including the checkpoint inhibitor Opdivo, the blood thinner Eliquis co-marketed with Pfizer, the cell therapies acquired with Celgene, and newer products such as the schizophrenia treatment Cobenfy. Headquartered in Princeton, New Jersey and listed on the New York Stock Exchange, it faces a heavy sequence of patent expiries and has been buying and licensing assets to replace them.
David Elkins · Chief Financial Officer · decision-maker
Christopher Boerner · Chairman and Chief Executive Officer · decision-maker
Careers mailbox is known
Senior • 7+ years exp • In office (Seattle, Madison, Princeton, Cambridge, United States) • Bachelor's Degree • Full-Time • Senior
Python
AI/ML
Machine Learning
Life Sciences
Flow Cytometry
Next-Generation Sequencing
Mass Spectrometry
$106k – $128k per year • Middle • 3+ years exp • In office (Cambridge, United States) • PhD • Full-Time • GMP / cleanroom • Middle
JMP
Life Sciences
qPCR
PCR
ELISA
Next-Generation Sequencing
GLP
LIMS
GraphPad Prism
$105k – $127k per year • Junior • 4+ years exp • In office (Cambridge, United States) • Bachelor's Degree • Full-Time • Senior
Irvine • San Diego • Indianapolis • Houston • Lincoln • Biotechnology • Hospitals & Health Systems • 201-500 employees • Hiring 50, 50 new
RENOVO SOLUTIONS provides research, life science and healthcare technology management solutions to help reduce costs, increase quality and improve medical.
No named decision-maker yet.
No careers mailbox known
≈ $74k – $153k per year (Estimated) • Middle • 4+ years exp • In office (Cambridge, United States) • Relocation • Associate's Degree • GMP / cleanroom • Middle
Mass Spectrometry
Chromatography
Cambridge • Biotechnology • Hiring 2, 2 new
We are advancing a pipeline of first-in-class ASO-based therapeutics with the potential to address diseases caused by insufficient protein expression.
No named decision-maker yet.
Careers mailbox is known
Top 25% payVerified live · 3 hours ago
4 days ago
Hiring now · 86%
Scientist I/II
$125k – $150k per year • Equity • Middle • In office (Cambridge, United States) • PhD • Middle
$177k – $240k per year • Equity • Head+ • 8+ years exp • In office (Cambridge, United States) • Master's Degree • Architect
HQ: Cambridge, United States • Vaccines • Infectious Disease Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 2010 • NASDAQ: MRNA • Trust B • Hiring 217, 21 new
Moderna is a global pharmaceutical and biotechnology enterprise pioneering messenger RNA therapeutics and vaccines. The company focuses on discovering and developing mRNA-based medicines to prevent and treat infectious diseases, immuno-oncology, and rare conditions. Headquartered in Cambridge, Massachusetts, it operates advanced research, development, and manufacturing networks worldwide to advance preventive and therapeutic health solutions.
No named decision-maker yet.
Careers mailbox is known
$272k – $490k per year • Equity • Head+ • 15+ years exp • In office (Cambridge, United States) • PhD • Full-Time • Nationals only • Architect
$131k – $209k per year • Equity • Senior • 2+ years exp • In office (Cambridge, United States) • PhD • Full-Time • Senior
Flow Cytometry
Antibody Engineering
$143k – $257k per year • Equity • Head+ • 8+ years exp • In office (Cambridge, United States) • Full-Time • Nationals only • Architect
HQ: Cambridge, United States • Biotechnology • Drug Discovery • NASDAQ: RLAY • Hiring 14, 1 new
Relay Therapeutics® puts protein motion at the heart of drug discovery to dramatically expand therapeutic possibilities.
Donald Bergstrom · Executive Officer · decision-maker
Brian Adams · Executive Officer · decision-maker
Sanjiv Patel · Executive Officer, Director · decision-maker
Peter Rahmer · Executive Officer · decision-maker
Careers mailbox is known
$69k – $99k per year • Senior • 2+ years exp • In office (Cambridge, United States) • Senior
$213k – $304k per year • Head+ • 5+ years exp • In office (Cambridge, United States) • PhD • Architect
$174k – $292k per year • Head+ • 6+ years exp • In office (Cambridge, United States) • Senior
HQ: Cambridge, United States • Biologics & Biosimilars • Drug Discovery • Likely startup • Hiring 2, 2 new
Extended-release RNA medicines that turn transient treatments into durable therapies for chronic disease. ScionxBio uses synthetic chemistry and AI to engineer xRNA — expanding the RNA alphabet for months-long protein expression.
No named decision-maker yet.
No careers mailbox known
In office (Cambridge, United States) • Master's Degree • Full-Time
Mass Spectrometry
HPLC
Chromatography
≈ $73k – $198k per year (Estimated) • In office (Cambridge, United States) • Master's Degree • Full-Time
Mass Spectrometry
HPLC
Chromatography
HQ: Cambridge, United States • Materials Science & Nanotechnology • Laboratory & Pharmaceutical Robotics • AI Research Labs • AI for Science • 201-500 employees • Est. 2023 • Startup • Trust A • Hiring 104, 6 new
Lila Sciences is an American company launched publicly in 2025 out of Flagship Pioneering with the aim of building what it calls scientific superintelligence: artificial intelligence systems that generate hypotheses and then test them in the company's own automated laboratories. Its distinguishing feature is the closed loop between model and experiment, since most scientific machine learning is limited by the fact that the data it needs has never been generated. Headquartered in Cambridge, Massachusetts and funded at an unusually large scale for a company at this stage, it is working across life sciences and materials chemistry rather than committing to a single field.
No named decision-maker yet.
Careers mailbox is known
$268k – $384k per year • Lead • In office (San Francisco, Cambridge, United States, London, United Kingdom) • PhD • Principal
HQ: Cambridge, United States • Cardiometabolic Therapeutics • Rare Disease Therapeutics • Cell & Gene Therapy • 51-200 employees • Est. 2002 • Hiring 101, 3 new
Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, that develops and commercialises RNA interference therapeutics for rare and common diseases, including ATTR amyloidosis and acute hepatic porphyria. Founded in Cambridge in 2002 and listed on the Nasdaq, it has six approved medicines available in more than 70 countries, a manufacturing site in Norton, Massachusetts, a European base in Maidenhead and an affiliate in Tokyo. It hires research and biology scientists, quality control analysts, clinical science and regulatory affairs staff, field reimbursement and key account managers, and IT, cyber defense and HR technology leaders.
No named decision-maker yet.
Careers mailbox is known
$223k – $314k per year • Head+ • Hybrid (Cambridge, United States) • Relocation • PhD • GMP / cleanroom • Senior
$117k – $158k per year • Senior • 8+ years exp • In office (Cambridge, United States) • PhD • Staff
$228k – $308k per year • Head+ • 12+ years exp • Hybrid (Cambridge, Philadelphia, United States) • Bachelor's Degree • Staff
HQ: Waltham, United States • CRO & CDMO Services • APIs & Drug Manufacturing • Clinical Trial Services (CRO) • Diagnostic Tests & IVD • Laboratory Equipment • 1001-5000 employees • Est. 2006 • NYSE: TMO • Trust B • Hiring 2652, 325 new
Founded in 2006 through a major merger, Thermo Fisher Scientific is a global leader in serving science, biotechnology, and healthcare. Headquartered in Waltham, Massachusetts, the multinational corporation provides a vast portfolio of analytical instruments, laboratory equipment, diagnostic tools, and pharmaceutical development services. By partnering with pharmaceutical companies, research institutions, and clinical laboratories worldwide, the organization enables clients to accelerate scientific discovery, optimize laboratory workflows, and improve patient diagnostics.
No named decision-maker yet.
No careers mailbox known
≈ $50k – $90k per year (Estimated) • Equity • Middle • 5+ years exp • In office (Cambridge, United States) • Bachelor's Degree • Full-Time • Middle • English: C1
Mass Spectrometry
HPLC
Chromatography
≈ $65k – $133k per year (Estimated) • Equity • Middle • 1+ year exp • In office (Cambridge, United States) • High School Diploma • Full-Time • Middle • English
≈ $86k – $164k per year (Estimated) • Equity • Senior • 2+ years exp • In office (Cambridge, United States) • High School Diploma • Full-Time • Senior • English: C1
